Mannitol Dose Response Study in Cystic Fibrosis

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Cystic Fibrosis
Interventions
DRUG

mannitol

120mg BD

DRUG

mannitol

40 mg BD

DRUG

mannitol

240mg BD

DRUG

mannitol

400mg BD

Trial Locations (12)

B1904CSI

Hospital de Niños Superiora Sor María Ludovica, La Plata

Unknown

Hospital Pediatrico, Resistencia

Hospital Interzonal Especializado Materno Infantil (HIEMI), Buenos Aires

Hospital General de Niños, CABA

Hospital Pediatrico Dr Humberto J Notti, Mendoza

St Michaels Hospital, Toronto

V6H 3V4

BC Children's Hospital, Vancouver

V6Z1Y6

St Pauls Hospital, Vancouver

A1B 3V6

Janeway Children's Health and Rehabilitation Center, St. John's

B3H 3A7

Queen Elizabeth II Health Sciences Centre, Halifax

L8N 3Z5

Hamilton Health Sciences Corporation, Hamilton

M5G 1X8

The Hospital for Sick Children, Toronto

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Syntara

INDUSTRY